| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BACKGROUND: The increasing popularity of continuous peripheral nerve blocks (CPNBs) warrants further study of their adverse effects and complications. METHODS: Anterior sciatic, femoral, and interscalene brachial plexus CPNBs were performed preoperatively using standardized catheter techniques in orthopedic patients prior to general or spinal anesthesia. Complications and adverse effects related to CPNBs were prospectively evaluated. RESULTS: We analyzed 1398 CPNBs in 849 consecutive patients (mean age 65 ± 13 yr) between 2002 and 2004. Two-hundred-twenty-one patients received interscalene, 628 patients femoral, and 549 sciatic CPNBs, respectively. In all the latter patients, we performed both femoral and sciatic CPNBs. Overall, there were 9 cases of local inflammation at the insertion site (0.6%), and 3 local infections (pustule) (0.2%, all femoral CPNBs). In one patient undergoing a femoral technique, a retroperitoneal hematoma led to compression injury of the femoral nerve. Complete denervation of the quadriceps femoris muscle was confirmed by electroneuromyography. No other major neurological complications were noted. There was one case of methemoglobinemia associated with an interscalene CPNB. Vascular puncture occurred in approximately 6% of patients undergoing femoral and sciatic CPNBs. Catheter rupture was noted in one patient. CONCLUSIONS: Our results add to the evidence that major complications from CPNBs are rare. However, minor adverse effects associated with CPNBs may be more common.
Peripheral nerve blocks provide many perioperative benefits, such as reduced opioid requirement, decreased incidence of hemodynamic instability, and less postoperative nausea and vomiting. Moreover, continuous peripheral nerve blocks (CPNBs) significantly improve postoperative pain control (1–7). Although recent studies have established the practicability, quality of pain control and patient satisfaction of various CPNB techniques (1,4,8–14), acceptance of CPNBs may, perhaps, be improved by increasing the availability of systematic data on complications and adverse effects (6,15–21). In the present study, we prospectively analyzed complications and adverse effects related to sciatic, femoral, and interscalene brachial plexus CPNBs performed in consecutive orthopedic patients.
This prospective analysis of consecutive orthopedic patients was approved by our institutional ethics committee and written informed consent was obtained from each patient. Complications and adverse effects associated with CPNBs, as well as details of the CPNB performance, were prospectively entered into a database between January 2002 and December 2004. Data from 200 patients analyzed in a preliminary study had been entered into the same database and were included in the present work (9).
Performance and Handling of CPNBs
Interscalene CPNB
Femoral Nerve CPNB
Anterior Sciatic Nerve CPNB
Study Design The primary end-point of our study was the rate of major complications (nerve injury, bleeding requiring surgical intervention, catheter-associated infection, dyspnea, pneumothorax, and local anesthetic systemic toxicity) associated with CPNBs. Secondary end-points were CPNB-associated minor adverse effects (e.g., uncomplicated accidental vascular puncture, hoarseness and Horners Syndrome). The daily postoperative check-up, performed by an anesthesiologist, included the inspection of the catheter insertion site for local hematoma and signs of local inflammation or infection (i.e., redness, induration, or pustule), check of body temperature and, if available, white blood cell count. Catheter-associated infection was suspected in patients with pustules, fever (>38°C), or white blood cell count >9000/mm3. These patients received antibiotics (Cefuroxime), the catheter was removed immediately and the distal portion (2–3 cm) was cut with sterile scissors, placed in a sterile transport medium, and sent to the microbiology laboratory for culture and sensitivity testing. In patients presenting signs of local inflammation (defined as redness, pain, and induration in the absence of pus) at the insertion site without concomitant symptoms the catheter was removed without further measures. In patients who had both femoral and sciatic CPNBs, both catheters were removed. The daily postoperative check-up also included the neurological examination of the operated limb for clinical features of nerve dysfunction (e.g., paresthesia, pain, or weakness) by an anesthesiologist. Patients with clinical features of nerve dysfunction persisting longer than 24 h after catheter removal were examined by a neurologist, on whose request electroneuromyography was performed to verify nerve injury. Neurological deficits resolving completely within 24 h after catheter removal were considered related to residual local anesthetic effect and are referred to as transient. Electroneuromyography was not performed in patients with transient neurological deficits. Likewise, patients with hoarseness did not undergo laryngoscopy. An aspiration test was performed daily by the orthopedic surgeon responsible for the administration of the local anesthetic in order to reduce the probability of intravascular migration of the catheter. Test doses with epinephrine were not used. The orthopedic surgeon also assessed the efficacy of the catheters qualitatively by asking the patients whether they experienced pain relief or not. CPNBs associated with inadequate analgesia were removed immediately.
Statistical Analysis
We analyzed 1398 CPNBs in 849 consecutive orthopedic patients, of which 500 (59%) were female. Demographic data and indications for CPNB are given in Table 1 and Figure 1. Complications and minor adverse effects are specified in Table 2.
Analyzing all CPNBs we noticed local inflammation at the insertion site of nine catheters (0.6%). Three patients (0.2%, all femoral CPNBs) presented with a pustule at the insertion site. In two of these, local infection could be confirmed by culture of the catheter, one was positive for Staphylococcus epidermidis and one for Staphylococcus aureus. The culture of the third catheter remained sterile. No patient presented with signs of systemic inflammation. Thirteen of the 1398 CPNBs (0.9%) were associated with neurological deficits persisting after catheter removal. The symptoms were transient in 12 of these patients. Only one CPNB (femoral technique) was complicated by permanent nerve injury. This patient complained of inguinal pain, numbness, and weakness of the thigh on the sixth day after total knee replacement. These symptoms persisted despite termination of the local anesthetic administration. Computed tomography revealed a retroperitoneal hematoma requiring surgical intervention. It is suspected that the bleeding most likely originated from the femoral artery, the direct injury of which, however, could not be verified. Complete denervation of the quadriceps femoris muscle was diagnosed by electroneuromyography and confirmed in repeat examinations. One patient (interscalene CPNB) presented with low oxygen saturation on pulse oximetry intraoperatively. Co-oximetry (ABL 625, Radiometer, Copenhagen, Denmark) revealed a methemoglobin level of 9%. There was one case of catheter breakage. During performance of a sciatic CPNB the catheter was withdrawn back into the needle after it had passed the tip and a 2-cm catheter fragment was shorn off at the bevel of the needle. As the fragment could not be localized, operative removal was declined by the orthopedic surgeon. No late occurring complications were noted at 6 and 12 mo follow-up.
The results of our study add to the body of evidence that major complications of CPNBs are rare. Nevertheless, our data confirm that minor adverse effects are not uncommon after interscalene, femoral, and sciatic CPNBs (6,15–17,19,23). In contrast to single-shot nerve blocks, catheter-induced complications need to be considered in addition to needle-induced and local anesthetic-induced complications when studying complications and adverse effects associated with CPNBs (23). Possible catheter-induced complications include infection and anatomical damage (e.g., intravascular or intrathecal migration) (6,17,19,20,24). Both the overall rates of local inflammation and infection observed in our patients correspond well with data from other groups (6,8,15–17,19,20). This is of interest to us, as we removed the catheters considerably later (Table 1, Fig. 1) than others who removed the catheters after 3–5 days (3,6,8,10,13,15–17,19,20). Moreover, we administered the local anesthetic as bolus on the ward which increased the frequency of catheter manipulations and could have increased the risk of infectious complications. As the analgesic approach requires consideration of orthopedic, physiotherapeutic, and anesthesiologic concerns, we let the orthopedic team decide when the catheters should be removed. This approach has led us to accept durations of around 4 days for interscalene, and around 6–8 days for femoral and sciatic CPNBs, respectively. However, as reported by Ben-David et al., such "standard institutional practice" should be challenged from time to time (3). For example, Pham Dang et al. noticed that the beneficial analgesic effects of sciatic CPNBs after total knee replacement disappear after 36 h (11). As an unusual catheter-associated complication we describe a case of catheter shearing. Although the retained catheter fragment caused neither irritation nor infection in our patient, one should ideally avoid withdrawing any catheters back into the needle (25). Our data confirm that major needle-induced complications are rare (15,23). In agreement with a previous report, we found that accidental vascular puncture was not uncommon during performance of femoral and sciatic CPNBs (17). Although accidental vascular puncture does not usually result in significant bleeding, hematoma formation can cause nerve injury due to pressure ischemia, either as perineural hematoma or by occupying and pressurizing an anatomic compartment, e.g., the retroperitoneum (as in our patient) or the axilla (26). In our patient, the unusual magnitude of bleeding may be explained by the patients self-medication with acetylsalicylic acid (1 g/day), which she did not disclose during the preanesthetic visit and continued postoperatively. We recognized only one local anesthetic-induced complication (methemoglobinemia). Although the incidence of seizures reportedly ranges from 1 to 4 per 1000 of regional anesthesia procedures, we observed neither seizures nor cardiovascular complications (21). Major complications of interscalene CPNBs are pneumothorax and impaired pulmonary function due to hemidiaphragmatic paresis. Common minor adverse effects are hoarseness and Horners Syndrome (8,10,13,18,23). We did not identify a single patient developing dyspnea or respiratory insufficiency after interscalene CPNB. However, since we neither performed routine postoperative chest radiograph nor sonography in asymptomatic patients, we cannot provide additional insight from our patients. Using Meier et al.s modification of Winnies approach (10), we found 14.5% of patients presenting transient hoarseness coinciding with regional anesthetic application. Horners Syndrome developed in 11.3% of patients. Compared to other reports, these effects occurred more often in our patients (8,10,13). Borgeat et al. reasoned that the incidence of hoarseness and Horners syndrome was less frequent when the local anesthetic was injected through the catheter and thus administered more caudally (8,13). This could explain the higher incidence in our patients because we injected the local anesthetic first and then inserted the catheter. However, Meier et al. used the same methodology but reported a lower incidence of hoarseness (10). Different doses of local anesthetic administered for postoperative analgesia could be an explanation.
Limitations of Our Study In conclusion, our results add to the existing evidence that major complications from CPNBs are rare. We also noted that minor adverse effects are not uncommon after CPNBs.
Accepted for publication February 8, 2007. Support was provided solely from institutional sources.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|